Please use this identifier to cite or link to this item:
https://ahro.austin.org.au/austinjspui/handle/1/32232| Title: | Seizure risk in multiple sclerosis patients treated with disease-modifying therapy: A systematic review and network meta-analysis. | Austin Authors: | Dang, Yew Li;Yong, Vivien Ty;Sharmin, Sifat;Perucca, Piero ;Kalincik, Tomas | Affiliation: | Neurology Department of Neurology, The Royal Melbourne Hospital, Melbourne, VIC, Australia/Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand/Department of Neurology, Auckland City Hospital, Auckland, New Zealand. CORe, Department of Medicine, The University of Melbourne, Melbourne, VIC, Australia. Neuroimmunology Centre, Department of Neurology, The Royal Melbourne Hospital, Melbourne, VIC, Australia/CORe, Department of Medicine, The University of Melbourne, Melbourne, VIC, Australia. |
Issue Date: | May-2023 | Date: | 2023-02 | Publication information: | Multiple sclerosis (Houndmills, Basingstoke, England) 2023-05; 29(6) | Abstract: | Multiple sclerosis patients experience 3-6 times more seizures than the general population, but observations vary among studies. Seizure risk in disease-modifying therapy recipients remains unknown. | URI: | https://ahro.austin.org.au/austinjspui/handle/1/32232 | DOI: | 10.1177/13524585231151400 | ORCID: | 0000-0002-0570-5398 0000-0003-3778-1376 |
Journal: | Multiple sclerosis | Start page: | 13524585231151400 | PubMed URL: | 36802988 | ISSN: | 1477-0970 | Type: | Journal Article | Subjects: | Multiple sclerosis disease-modifying therapies epilepsy meta-analysis seizures systematic review |
| Appears in Collections: | Journal articles |
Show full item record
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.